跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COMIRNATY 30 MICROGRAMOS/DOSIS DISPERSION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
COMIRNATY 30 MICROGRAMOS/DOSIS DISPERSION INYECTABLE
Approved
STANDARD
COMIRNATY 30 MICROGRAMOS/DOSIS DISPERSION INYECTABLE
Biontech Manufacturing Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 26, 2021
Approval ID
e4b3ed54e9050289
Company
Biontech Manufacturing Gmbh
Type
Standard
Approval Details
Approval Id
e4b3ed54e9050289
Drug Cima Aemps Name
COMIRNATY 30 MICROGRAMOS/DOSIS DISPERSION INYECTABLE
Register Number
1201528002
Holder Company Name
Biontech Manufacturing Gmbh
Marketing Company Name
Pfizer S.L.
Holder Company Detail Path
/organization/biontech-manufacturing-gmbh
Authorization Date
2021-11-26
Dosage Form
DISPERSIÓN INYECTABLE
Dose
0,3 microgramos/0,3 ml
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Biontech Manufacturing Gmbh
Company Detail Path
/organization/biontech-manufacturing-gmbh
Company Information
Pharmaceutical Company Name
BioNTech Manufacturing GmbH
Country Name
Germany
Active Ingredients
TOZINAMERAN
0,1 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 26, 2021
Approval ID
e4b3ed54e9050289
Type
Standard
Back to CIMA-AEMPS Approvals
